Point mutations in the human BRAF gene are associated with a group of heterogeneous autosomal dominant neuro-cardio-facial-cutaneous syndromes. We identified a novel 93 kb intragenic deletion of the BRAF gene in a boy with severe developmental encephalopathy using microarray-based comparative genomic hybridization. The unique genotype and phenotype in this patient expands the spectrum of BRAF-related neurodevelopmental disorders. We propose a BRAF gene loss-of-function mechanism to best explain the biological basis of this severe developmental encephalopathy with postnatal growth deficiency.
NiihoriTAokiYNarumiY.Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet. 2006;38:294–296.
2.
Bentires-AljMKontaridisMINeelBG.Stops along the RAS pathway in human genetic disease. Nat Med. 2006;12:283–285.
3.
SarkozyACartaCMorettiS.Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat. 2009;30:695–702.
4.
AokiYNiihoriTNarumiY.The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat. 2008;29:992–1006.
5.
Rodriguez-VicianaPTetsuOTidymanWE.Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science. 2006;311:1287–1290.
6.
SamuelsISSaittaSCLandrethGE.MAP’ing CNS development and cognition: an ERKsome process. Neuron. 2009;61:160–167.
7.
ArmourCMAllansonJE.Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations. J Med Genet. 2008;45:249–254.
8.
NarumiYAokiYNiihoriT.Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome. J Hum Genet. 2008;53:834–841.
9.
YuSBittelDCKibiryevaN.Validation of the Agilent 244K oligonucleotide array-based comparative genomic hybridization platform for clinical cytogenetic diagnosis. Am J Clin Pathol. 2009;132:349–360.
10.
YuSKieltMStegnerAL.Quantitative real-time polymerase chain reaction for the verification of genomic imbalances detected by microarray-based comparative genomic hybridization. Genet Test Mol Biomarkers. 2009;13:751–760.
11.
ShaikhTHGaiXPerinJC.High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res. 2009;19:1682–1690.
12.
ItsaraACooperGMBakerC.Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet. 2009;84:148–161.
13.
MercerKEPritchardCA.Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta. 2003;1653:25–40.
14.
WojnowskiLZimmerAMBeckTW.Endothelial apoptosis in Braf-deficient mice. Nat Genet. 1997;16:293–297.
15.
Galabova-KovacsGMatzenDPiazzollaD.Essential role of B-Raf in ERK activation during extraembryonic development. Proc Natl Acad Sci U S A. 2006;103:1325–1330.
16.
MorettiSDe FalcoVTamburrinoA.Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif. Biochim Biophys Acta. 2009;1793:1634–1645.
17.
VermaRSConteRASayeghSEKanjilalD.The interstitial deletion of bands q33-35 of long arm of chromosome 7: a review with a new case report. Clin Genet. 1992;41:82–86.
De LucaABottilloIDasdiaMC.Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. J Med Genet. 2007;44:800–808.
20.
ShchelochkovOAPatelAWeissenbergerGM.Duplication of chromosome band 12q24.11q24.23 results in apparent Noonan syndrome. Am J Med Genet A. 2008;146A:1042–1048.
21.
GrahamJMJrKramerNBejjaniBA.Genomic duplication of PTPN11 is an uncommon cause of Noonan syndrome. Am J Med Genet A. 2009;149A:2122–2128.
22.
GrisartBRackKVidrequinS.NF1 microduplication first clinical report: association with mild mental retardation, early onset of baldness and dental enamel hypoplasia?. Eur J Hum Genet. 2008;16:305–311.
